Indications |
Oral Hypertension, Prinzmetal's angina, Stable angina Adult: Initially, 5 mg once daily increased to 10 mg once daily if necessary. Elderly: Initial dose: 2.5 mg once daily. Hepatic impairment: Initial dose: 2.5 mg once daily. |
Contraindications |
Known hypersensitivity to dihydropyridines. |
Warnings / Precautions |
Impaired liver or renal function, CHF, sick-sinus syndrome, severe ventricular dysfunction, hypertrophic cardiomyopathy, severe aortic stenosis. Caution when used in patients with idiopathic hypertrophic subaortic stenosis. Elderly, children. Pregnancy, lactation. |
Adverse Reactions |
Headache, peripheral oedema, fatigue, somnolence, nausea, abdominal pain, flushing, dyspepsia, palpitations, dizziness. Rarely pruritus, rash, dyspnoea, asthenia, muscle cramps. Potentially Fatal: Hypotension, bradycardia, conductive system delay and CCF. |
Overdose Reactions |
Overdosage may cause marked peripheral vasodilation and hypotension. |
Drug Interactions |
Increased metabolism with rifampin. Reduced hypotensive effect with calcium. Potentiates effects of thiazide diuretics and ACE inhibitors. Avoid combination with β-blockers in patients with markedly impaired left ventricular function. May increase serum levels of CYP1A2 substrates e.g. aminophylline, fluvoxamine, ropinirole. CYP3A4 inhibitors (e.g. clarithromycin, doxycycline, isoniazid, nicardipine) may increase the effects of amlodipine. Additive BP-lowering effects when used with sildenafil, tadalafil or vardenafil. See Below for More amlodipine Drug Interactions |
Mechanism of Actions |
Amlodipine relaxes peripheral and coronary vascular smooth muscle. It produces coronary vasodilation by inhibiting the entry of Ca ions into the voltage-sensitive channels of the vascular smooth muscle and myocardium during depolarisation. It also increases myocardial O2 delivery in patients with vasospastic angina. Absorption: Well absorbed from the GI tract (oral); peak plasma concentrations after 6-12 hr. Distribution: Protein-binding: 97.5%. Metabolism: Hepatic: Extensive. Excretion: Via urine (mainly as metabolites, 10% as unchanged); 35-50 hr (elimination half-life). |
Administration |
May be taken with or without food. |
Storage Conditions |
Oral: Store at 15-30°C. |
ATC Classification |
C08CA01 - amlodipine ; Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases. |
Storage |
Oral: Store at 15-30°C. |
Available As |
|
Amlodipine
Post Review about Amlodipine Click here to cancel reply.
Amlodipine Containing Brands
Amlodipine is used in following diseases
Drug - Drug Interactions of Amlodipine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.